The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hemostats and Tissue Sealants-Global Market Insights and Sales Trends 2024
Synopsis
Blood clotting or coagulation, is an important process that eliminates excessive bleeding when a blood vessel is damaged. Platelets and proteins work together to stop the bleeding by forming a clot over the injury. Blood clottage is one of the mechanisms that reduce the loss of blood from damaged blood vessels. Hemostats and tissue sealants are used post-surgery or traumatic injury to bind or hold external tissue (skin) as well as internal tissue (blood vessels). Some key types of hemostats and tissue sealants include fibrin sealants, collagen-based compounds, synthetic agents, and tissue adhesive glues such as hydrogels and glutaraldehyde glues. Fibrin sealants have a wide range of medical applications.
The global Hemostats and Tissue Sealants market size is expected to reach US$ 5088.3 million by 2029, growing at a CAGR of 6.0% from 2023 to 2029. The market is mainly driven by the significant applications of Hemostats and Tissue Sealants in various end use industries. The expanding demands from the Clinical Medicine and Scientific Research, are propelling Hemostats and Tissue Sealants market. Hemostats, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tissue Sealants segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hemostats and Tissue Sealants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hemostats and Tissue Sealants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hemostats and Tissue Sealants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hemostats and Tissue Sealants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hemostats and Tissue Sealants covered in this report include Baxter, CR Bard, Johnson & Johnson, B.Braun, Cardinal Health, Cryolife, Neomend, Vivostat and Z-Medica, etc.
The global Hemostats and Tissue Sealants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter
CR Bard
Johnson & Johnson
B.Braun
Cardinal Health
Cryolife
Neomend
Vivostat
Z-Medica
Global Hemostats and Tissue Sealants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hemostats and Tissue Sealants market, Segment by Type:
Hemostats
Tissue Sealants
Global Hemostats and Tissue Sealants market, by Application
Clinical Medicine
Scientific Research
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hemostats and Tissue Sealants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hemostats and Tissue Sealants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Blood clotting or coagulation, is an important process that eliminates excessive bleeding when a blood vessel is damaged. Platelets and proteins work together to stop the bleeding by forming a clot over the injury. Blood clottage is one of the mechanisms that reduce the loss of blood from damaged blood vessels. Hemostats and tissue sealants are used post-surgery or traumatic injury to bind or hold external tissue (skin) as well as internal tissue (blood vessels). Some key types of hemostats and tissue sealants include fibrin sealants, collagen-based compounds, synthetic agents, and tissue adhesive glues such as hydrogels and glutaraldehyde glues. Fibrin sealants have a wide range of medical applications.
The global Hemostats and Tissue Sealants market size is expected to reach US$ 5088.3 million by 2029, growing at a CAGR of 6.0% from 2023 to 2029. The market is mainly driven by the significant applications of Hemostats and Tissue Sealants in various end use industries. The expanding demands from the Clinical Medicine and Scientific Research, are propelling Hemostats and Tissue Sealants market. Hemostats, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tissue Sealants segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hemostats and Tissue Sealants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hemostats and Tissue Sealants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hemostats and Tissue Sealants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hemostats and Tissue Sealants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hemostats and Tissue Sealants covered in this report include Baxter, CR Bard, Johnson & Johnson, B.Braun, Cardinal Health, Cryolife, Neomend, Vivostat and Z-Medica, etc.
The global Hemostats and Tissue Sealants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter
CR Bard
Johnson & Johnson
B.Braun
Cardinal Health
Cryolife
Neomend
Vivostat
Z-Medica
Global Hemostats and Tissue Sealants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hemostats and Tissue Sealants market, Segment by Type:
Hemostats
Tissue Sealants
Global Hemostats and Tissue Sealants market, by Application
Clinical Medicine
Scientific Research
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hemostats and Tissue Sealants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hemostats and Tissue Sealants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Hemostats and Tissue Sealants Market Overview
1.1 Hemostats and Tissue Sealants Product Overview
1.2 Hemostats and Tissue Sealants Market Segment by Type
1.2.1 Hemostats
1.2.2 Tissue Sealants
1.3 Global Hemostats and Tissue Sealants Market Size by Type
1.3.1 Global Hemostats and Tissue Sealants Market Size Overview by Type (2018-2029)
1.3.2 Global Hemostats and Tissue Sealants Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hemostats and Tissue Sealants Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hemostats and Tissue Sealants Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hemostats and Tissue Sealants Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hemostats and Tissue Sealants Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hemostats and Tissue Sealants Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hemostats and Tissue Sealants Sales Breakdown by Type (2018-2023)
2 Global Hemostats and Tissue Sealants Market Competition by Company
2.1 Global Top Players by Hemostats and Tissue Sealants Sales (2018-2023)
2.2 Global Top Players by Hemostats and Tissue Sealants Revenue (2018-2023)
2.3 Global Top Players by Hemostats and Tissue Sealants Price (2018-2023)
2.4 Global Top Manufacturers Hemostats and Tissue Sealants Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hemostats and Tissue Sealants Market Competitive Situation and Trends
2.5.1 Hemostats and Tissue Sealants Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hemostats and Tissue Sealants Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hemostats and Tissue Sealants as of 2022)
2.7 Date of Key Manufacturers Enter into Hemostats and Tissue Sealants Market
2.8 Key Manufacturers Hemostats and Tissue Sealants Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hemostats and Tissue Sealants Status and Outlook by Region
3.1 Global Hemostats and Tissue Sealants Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hemostats and Tissue Sealants Historic Market Size by Region
3.2.1 Global Hemostats and Tissue Sealants Sales in Volume by Region (2018-2023)
3.2.2 Global Hemostats and Tissue Sealants Sales in Value by Region (2018-2023)
3.2.3 Global Hemostats and Tissue Sealants Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hemostats and Tissue Sealants Forecasted Market Size by Region
3.3.1 Global Hemostats and Tissue Sealants Sales in Volume by Region (2024-2029)
3.3.2 Global Hemostats and Tissue Sealants Sales in Value by Region (2024-2029)
3.3.3 Global Hemostats and Tissue Sealants Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hemostats and Tissue Sealants by Application
4.1 Hemostats and Tissue Sealants Market Segment by Application
4.1.1 Clinical Medicine
4.1.2 Scientific Research
4.2 Global Hemostats and Tissue Sealants Market Size by Application
4.2.1 Global Hemostats and Tissue Sealants Market Size Overview by Application (2018-2029)
4.2.2 Global Hemostats and Tissue Sealants Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hemostats and Tissue Sealants Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hemostats and Tissue Sealants Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hemostats and Tissue Sealants Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hemostats and Tissue Sealants Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hemostats and Tissue Sealants Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hemostats and Tissue Sealants Sales Breakdown by Application (2018-2023)
5 North America Hemostats and Tissue Sealants by Country
5.1 North America Hemostats and Tissue Sealants Historic Market Size by Country
5.1.1 North America Hemostats and Tissue Sealants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hemostats and Tissue Sealants Sales in Volume by Country (2018-2023)
5.1.3 North America Hemostats and Tissue Sealants Sales in Value by Country (2018-2023)
5.2 North America Hemostats and Tissue Sealants Forecasted Market Size by Country
5.2.1 North America Hemostats and Tissue Sealants Sales in Volume by Country (2024-2029)
5.2.2 North America Hemostats and Tissue Sealants Sales in Value by Country (2024-2029)
6 Europe Hemostats and Tissue Sealants by Country
6.1 Europe Hemostats and Tissue Sealants Historic Market Size by Country
6.1.1 Europe Hemostats and Tissue Sealants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hemostats and Tissue Sealants Sales in Volume by Country (2018-2023)
6.1.3 Europe Hemostats and Tissue Sealants Sales in Value by Country (2018-2023)
6.2 Europe Hemostats and Tissue Sealants Forecasted Market Size by Country
6.2.1 Europe Hemostats and Tissue Sealants Sales in Volume by Country (2024-2029)
6.2.2 Europe Hemostats and Tissue Sealants Sales in Value by Country (2024-2029)
7 Asia-Pacific Hemostats and Tissue Sealants by Region
7.1 Asia-Pacific Hemostats and Tissue Sealants Historic Market Size by Region
7.1.1 Asia-Pacific Hemostats and Tissue Sealants Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hemostats and Tissue Sealants Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hemostats and Tissue Sealants Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hemostats and Tissue Sealants Forecasted Market Size by Region
7.2.1 Asia-Pacific Hemostats and Tissue Sealants Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hemostats and Tissue Sealants Sales in Value by Region (2024-2029)
8 Latin America Hemostats and Tissue Sealants by Country
8.1 Latin America Hemostats and Tissue Sealants Historic Market Size by Country
8.1.1 Latin America Hemostats and Tissue Sealants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hemostats and Tissue Sealants Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hemostats and Tissue Sealants Sales in Value by Country (2018-2023)
8.2 Latin America Hemostats and Tissue Sealants Forecasted Market Size by Country
8.2.1 Latin America Hemostats and Tissue Sealants Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hemostats and Tissue Sealants Sales in Value by Country (2024-2029)
9 Middle East and Africa Hemostats and Tissue Sealants by Country
9.1 Middle East and Africa Hemostats and Tissue Sealants Historic Market Size by Country
9.1.1 Middle East and Africa Hemostats and Tissue Sealants Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hemostats and Tissue Sealants Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hemostats and Tissue Sealants Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hemostats and Tissue Sealants Forecasted Market Size by Country
9.2.1 Middle East and Africa Hemostats and Tissue Sealants Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hemostats and Tissue Sealants Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Baxter
10.1.1 Baxter Company Information
10.1.2 Baxter Introduction and Business Overview
10.1.3 Baxter Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Baxter Hemostats and Tissue Sealants Products Offered
10.1.5 Baxter Recent Development
10.2 CR Bard
10.2.1 CR Bard Company Information
10.2.2 CR Bard Introduction and Business Overview
10.2.3 CR Bard Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CR Bard Hemostats and Tissue Sealants Products Offered
10.2.5 CR Bard Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Company Information
10.3.2 Johnson & Johnson Introduction and Business Overview
10.3.3 Johnson & Johnson Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Johnson & Johnson Hemostats and Tissue Sealants Products Offered
10.3.5 Johnson & Johnson Recent Development
10.4 B.Braun
10.4.1 B.Braun Company Information
10.4.2 B.Braun Introduction and Business Overview
10.4.3 B.Braun Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.4.4 B.Braun Hemostats and Tissue Sealants Products Offered
10.4.5 B.Braun Recent Development
10.5 Cardinal Health
10.5.1 Cardinal Health Company Information
10.5.2 Cardinal Health Introduction and Business Overview
10.5.3 Cardinal Health Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Cardinal Health Hemostats and Tissue Sealants Products Offered
10.5.5 Cardinal Health Recent Development
10.6 Cryolife
10.6.1 Cryolife Company Information
10.6.2 Cryolife Introduction and Business Overview
10.6.3 Cryolife Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Cryolife Hemostats and Tissue Sealants Products Offered
10.6.5 Cryolife Recent Development
10.7 Neomend
10.7.1 Neomend Company Information
10.7.2 Neomend Introduction and Business Overview
10.7.3 Neomend Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Neomend Hemostats and Tissue Sealants Products Offered
10.7.5 Neomend Recent Development
10.8 Vivostat
10.8.1 Vivostat Company Information
10.8.2 Vivostat Introduction and Business Overview
10.8.3 Vivostat Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Vivostat Hemostats and Tissue Sealants Products Offered
10.8.5 Vivostat Recent Development
10.9 Z-Medica
10.9.1 Z-Medica Company Information
10.9.2 Z-Medica Introduction and Business Overview
10.9.3 Z-Medica Hemostats and Tissue Sealants Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Z-Medica Hemostats and Tissue Sealants Products Offered
10.9.5 Z-Medica Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hemostats and Tissue Sealants Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hemostats and Tissue Sealants Industrial Chain Analysis
11.4 Hemostats and Tissue Sealants Market Dynamics
11.4.1 Hemostats and Tissue Sealants Industry Trends
11.4.2 Hemostats and Tissue Sealants Market Drivers
11.4.3 Hemostats and Tissue Sealants Market Challenges
11.4.4 Hemostats and Tissue Sealants Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hemostats and Tissue Sealants Distributors
12.3 Hemostats and Tissue Sealants Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
